TRxADE HEALTH, Inc Files Its Q3 10-Q For The Period Ended September 30, 2023
Portfolio Pulse from Benzinga Newsdesk
TRxADE HEALTH, Inc. (NASDAQ:MEDS) filed its Q3 10-Q report for the period ending September 30, 2023. The company previously received a notice of noncompliance from Nasdaq due to the late filing but believes it has now regained compliance with the filing of its Form 10-Q.
January 17, 2024 | 2:17 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
TRxADE HEALTH, Inc. filed its overdue Q3 10-Q report, potentially resolving issues related to Nasdaq noncompliance.
Filing the overdue 10-Q report is a positive step towards regulatory compliance, which can alleviate concerns from investors and may have a positive impact on the stock price in the short term. However, the impact may be moderated by the market's perception of the company's overall financial health as detailed in the 10-Q.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100